Skip to main content
. 2017 Mar 26;7(1):9–15. doi: 10.5662/wjm.v7.i1.9

Table 3.

Chromogranin A diagnostic accuracy in neuroendocrine tumor studies

Type (no pts) CgA cut-off Sensitivity (%) Specificity (%) Ref.
NET (128) 100 μg/L 59 68 [57]
NET (127) 34.7 u/L 67.9 85.7 [35]
NET (80) 17 u/L 56.3 100 [58]
NET (63) 34 u/L 55 94 [59]
GEP/NET (61) 20 u/L 92 83 [50]
100 u/L 47 99
GEP/NET (124) 130 μg/L 62.9 98.4 [16]
GEP/NET (202) 53 ng/mL 71.3 77.8 [60]
NET (120) 98 ng/mL 79 NA [61]
GEP/NET (119) 2.8 nmol/L 92.9 100 [62]

no: Number; pts: Patients; NA: Non available; CgA: Chromogranin A; NET: Neuroendocrine tumor; GEP: Gastroenteropancreatic.